Clinical Trial

OE MRI to Predict Treatment Response After TACE in HCC Patients

Name: OE MRI to Predict Treatment Response After TACE in HCC Patients — clinical trial record (NCT07617038)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: HERO

Enrolling by Invitation

View on ClinicalTrials.gov →

Summary

To predict response of HCC to TACE using dynamic oxygen-enhanced (dOE)-MRI for assessment of the level of tumor hypoxia before and after treatment.

Trial Details

NCT Number	NCT07617038
Lead Sponsor	Université de Montréal Collaborators: Laboratory ISTCT UMR6030 CNRS of Caen (France), Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Conditions	HCC - Hepatocellular Carcinoma, TACE, SIRT
Enrollment	60 participants
Start Date	2024-11-27
Primary Completion	2027-12-20 (estimated)
Study Completion	2029-12-20 (estimated)
Updated on ClinicalTrials.gov	2026-06-01